Curevac N.V. Stock
Price
Target price
€2.17
€2.17
0.090%
0.002
0.090%
€8.00
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Curevac N.V. Stock
With only a change of €0.002 (0.090%) the Curevac N.V. price is nearly unchanged from yesterday.
The community is currently still undecided about Curevac N.V. with 1 Buy predictions and 1 Sell predictions.
With a target price of 8 € there is potential for a 268.32% increase which would mean more than doubling the current price of 2.17 € for Curevac N.V..
Our community identified positive and negative aspects for Curevac N.V. stock for the coming years. 19 users see the criterium "Worthwhile Investment for the next years" as a plus for the Curevac N.V. stock. On the other hand our users think that "General Risks" could be a problem in the future.
Pros and Cons of Curevac N.V. in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
M***** P*******
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Comments
.png?locale=us "FinanceClub_UoM")
News
EQS-News: CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update
EQS-News: CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update
EQS-News: CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK
EQS-News: CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK
EQS-News: CureVac Appoints Thaminda Ramanayake as New Chief Business Officer
EQS-News: CureVac Appoints Thaminda Ramanayake as New Chief Business Officer